tiprankstipranks
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
US Market

Relmada Therapeutics (RLMD) Technical Analysis

Compare
335 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Relmada Therapeutics’s (RLMD) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Relmada Therapeutics is a Sell.
Relmada Therapeutics’s (RLMD) 20-Day exponential moving average is 0.29, while Relmada Therapeutics’s (RLMD) share price is $0.27, making it a Sell.
Relmada Therapeutics’s (RLMD) 50-Day exponential moving average is 0.42, while Relmada Therapeutics’s (RLMD) share price is $0.27, making it a Sell.

Relmada Therapeutics (RLMD) Pivot Points

Apr 05, 2025, 01:02 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.23
0.24
0.26
0.28
0.29
0.31
0.32
Fibonacci
0.24
0.26
0.26
0.28
0.29
0.30
0.31
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relmada Therapeutics (RLMD) Moving Averages

Apr 05, 2025, 01:02 PM
Period
Simple
Exponential
MA5
0.28Sell
0.29Sell
MA10
0.29Sell
0.29Sell
MA20
0.29Sell
0.29Sell
MA50
0.31Sell
0.42Sell
MA100
0.83Sell
0.90Sell
MA200
2.06Sell
1.87Sell
Relmada Therapeutics’s (RLMD) 10-Day exponential moving average is 0.29, while Relmada Therapeutics’s (RLMD) share price is $0.27, making it a Sell.
Relmada Therapeutics’s (RLMD) 100-Day exponential moving average is 0.90, while Relmada Therapeutics’s (RLMD) share price is $0.27, making it a Sell.
Relmada Therapeutics’s (RLMD) stock price is $0.27 and Relmada Therapeutics’s (RLMD) 50-day simple moving average is 0.31, creating a Sell signal.
Relmada Therapeutics’s (RLMD) stock price is $0.27 and Relmada Therapeutics’s (RLMD) 100-day simple moving average is 0.83, creating a Sell signal.
Relmada Therapeutics’s (RLMD) stock price is $0.27 and Relmada Therapeutics’s (RLMD) 200-day simple moving average is 2.06, creating a Sell signal.

Relmada Therapeutics (RLMD) Technical Indicators

Apr 05, 2025, 01:02 PM
Name
Value
Implied Action
RSI (14)
36.82
Neutral
STOCH (9,6)
31.25
Neutral
STOCHRSI (14)
33.07
Neutral
MACD (12,26)
-0.01
Sell
ADX (14)
13.80
Buy
Williams %R
-84.37
Buy
CCI (14)
-77.63
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
56.06
Neutral
ROC
-3.45
Sell
Relmada Therapeutics’s (RLMD) Relative Strength Index (RSI) is 36.82, creating a Neutral signal.
Relmada Therapeutics’s (RLMD) Trend Strength Indicator (ADX) is 13.80, creating a Buy signal.
Relmada Therapeutics’s (RLMD) Commodity Channel Index (CCI) is -77.63, creating a Neutral signal.
Relmada Therapeutics’s (RLMD) Price Rate of Change (ROC) is -3.45, creating a Sell signal.

FAQ

Is RLMD a Buy, Hold, or Sell?
Based on RLMD’s technical indicators, RLMD is a Strong Sell.
    What is RLMD’s RSI (14)?
    RLMD’s RSI (14) is 36.82, which suggests RLMD is a Neutral.
      What is RLMD’s MACD?
      RLMD’s MACD is -0.01, which suggests RLMD is a Sell.
        What is RLMD’s 5-day moving average?
        RLMD’s 5-day moving average is 0.28, which suggests RLMD is a Sell.
          What is RLMD’s 20-day moving average?
          RLMD 20-day moving average is 0.29, which suggests RLMD is a Sell.
            What is RLMD’s 50-day moving average?
            RLMD’s 50-day moving average is 0.31, which suggests RLMD is a Sell.
              What is RLMD’s 200-day moving average?
              RLMD’s 200-day moving average is 2.06, which suggests RLMD is a Sell.
                What is RLMD’s Williams % R (14)?
                RLMD’s Williams % R (14) is -84.37, which suggests RLMD is a Buy.
                  What is RLMD’s CCI (14)?
                  RLMD’s CCI (14) is -77.63, which suggests RLMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis